Safety and immunogenicity of a killed bivalent (O1 and O139) whole-cell oral cholera vaccine in adults and children in Vellore, South India

This open-label study assessed the safety and immunogenicity of two doses (14 days apart) of an indigenously manufactured, killed, bivalent (Vibrio cholerae O1 and O139), whole-cell oral cholera vaccine (SHANCHOL; Shantha Biotechnics) in healthy adults (n = 100) and children (n = 100) in a cholera e...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:PLoS One
Main Authors: Raghava Mohan, Venkata, Raj, Santosh, Dhingra, Mandeep Singh, Aloysia D’Cor, Naveena, Singh, Ajit Pal, Saluja, Tarun, Kim, Deok Ryun, Midde, Venkat Jayanth, Kim, Yanghee, Vemula, Sridhar, Narla, Santhosh Kumar, Sah, Binod, Ali, Mohammad
Formato: Artigo
Idioma:Inglês
Publicado: Public Library of Science 2019
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6581248/
https://ncbi.nlm.nih.gov/pubmed/31211792
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0218033
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares